Novartis receives FDA approval for Kisqali Femara Co-Pack for initial treatment of HR+/HER2- advanced or metastatic breast cancer

Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”

When Robert A. Winn was named director of the University of Illinois Cancer Center in 2015, he knew that the skills required to be a successful cancer center director were very different from the skills he drew upon to be a successful scientist. So, he formed an informal, personal mentorship team.

September 03, 2025

Podcast

Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book

In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.

August 27, 2025

Conversation with The Cancer Letter Podcast

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Phil and Penny Knight made a record-setting $2 billion gift to OHSU Knight Cancer Institute.

August 14, 2025

By Paul Goldberg and Sara Willa Ernst

Podcast

In The Headlines: Late poet Andrea Werblin Reid’s husband talks about publishing her final collection about dying from ovarian cancer

In the last three years of her life, Andrea Werblin Reid wrote 150 poems on living with ovarian cancer and end of life. Werblin Reid died of ovarian cancer in 2022. Her third collection of poetry, “To See Yourself As You Vanish,” will be published Sept. 9.

August 13, 2025

Vol.51 No.31

Podcast The Directors

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Mary Beckerle, a whitewater kayaker, has advice for all the folks in the cancer field: never catastrophize, never panic.

Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death

I always liked poetry, but I was never a poet. I had to marry into that.

August 08, 2025

Vol.51 No.31

By Angus (Gus) Reid

Novartis receives FDA approval for Kisqali Femara Co-Pack for initial treatment of HR+/HER2- advanced or metastatic breast cancer

YOU MAY BE INTERESTED IN

Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”

Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

In The Headlines: Late poet Andrea Werblin Reid’s husband talks about publishing her final collection about dying from ovarian cancer

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death

Renew today!

Subscriber content

Never miss an issue!

Login

Novartis receives FDA approval for Kisqali Femara Co-Pack for initial treatment of HR+/HER2- advanced or metastatic breast cancer

YOU MAY BE INTERESTED IN

Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”

Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSUBrian Druker returns to executive role as president of the new Knight Cancer Group

In The Headlines: Late poet Andrea Werblin Reid’s husband talks about publishing her final collection about dying from ovarian cancer

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five statesHonoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and lossHer collection, “To See Yourself As You Vanish,” will be published three years after her death

Never miss an issue!

Login

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death